Literature DB >> 19047175

Chromosome 12p deletions in TEL-AML1 childhood acute lymphoblastic leukemia are associated with retrotransposon elements and occur postnatally.

Joseph L Wiemels1, Jerry Hofmann, Michelle Kang, Rebecca Selzer, Roland Green, Mi Zhou, Sheng Zhong, Luoping Zhang, Martyn T Smith, Carmen Marsit, Mignon Loh, Patricia Buffler, Ru-Fang Yeh.   

Abstract

TEL-AML1 (ETV6-RUNX1) is the most common translocation in the childhood leukemias, and is a prenatal mutation in most children. This translocation has been detected at a high rate among newborns ( approximately 1%); therefore, the rate-limiting event for leukemia seems to be secondary mutations. One such frequent mutation in this subtype is partial deletion of chromosome 12p, trans from the translocation. Nine del(12p) breakpoints within six leukemia cases were sequenced to explore the etiology of this genetic event, and most involved cryptic sterile translocations. Twelve of 18 del(12p) parent sequences involved in these breakpoints were located in repeat regions (8 of these in long interspersed nuclear elements). This stands in contrast with TEL-AML1, in which only 21 of 110 previously assessed breakpoints (19%) occur in DNA repeats (P=0.0001). An exploratory assessment of archived neonatal blood cards revealed significantly more long interspersed nuclear element CpG methylations in individuals at birth who were later diagnosed with TEL-AML1 leukemia, compared with individuals who did not contract leukemia (P=0.01). Nontemplate nucleotides were also more frequent in del(12p) than in TEL-AML1 junctions (P=0.004), suggesting formation by terminal deoxynucleotidyl transferase. Assessment of six archived neonatal blood cards indicated that no del(12p) rearrangements backtracked to birth, although two of these patients were previously positive for TEL-AML1 using the same assay with comparable sensitivity. These data are compatible with a two-stage natural history: TEL-AML1 occurs prenatally, and del(12p) occurs postnatally in more mature cells with a structure that suggests the involvement of retrotransposon instability.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19047175      PMCID: PMC2597307          DOI: 10.1158/0008-5472.CAN-08-2139

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  53 in total

1.  Silencing of transgene transcription precedes methylation of promoter DNA and histone H3 lysine 9.

Authors:  Vesco Mutskov; Gary Felsenfeld
Journal:  EMBO J       Date:  2003-12-11       Impact factor: 11.598

2.  Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection.

Authors:  E Renate Panzer-Grümayer; Giovanni Cazzaniga; Vincent H J van der Velden; Laura del Giudice; Martina Peham; Georg Mann; Conny Eckert; Andre Schrauder; Giuseppe Germano; Jochen Harbott; Giuseppe Basso; Andrea Biondi; Jacques J M van Dongen; Helmut Gadner; Oskar A Haas
Journal:  Clin Cancer Res       Date:  2005-11-01       Impact factor: 12.531

3.  Origins of "late" relapse in childhood acute lymphoblastic leukemia with TEL-AML1 fusion genes.

Authors:  A M Ford; K Fasching; E R Panzer-Grümayer; M Koenig; O A Haas; M F Greaves
Journal:  Blood       Date:  2001-08-01       Impact factor: 22.113

Review 4.  Leukemia in twins: lessons in natural history.

Authors:  Mel F Greaves; Ana Teresa Maia; Joseph L Wiemels; Anthony M Ford
Journal:  Blood       Date:  2003-06-05       Impact factor: 22.113

5.  Cross-lineage T cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual disease.

Authors:  T Szczepański; A Beishuizen; M J Pongers-Willemse; K Hählen; E R Van Wering; A J Wijkhuijs; G J Tibbe; M A De Bruijn; J J Van Dongen
Journal:  Leukemia       Date:  1999-02       Impact factor: 11.528

6.  Analysis of chromosome breakpoints in neuroblastoma at sub-kilobase resolution using fine-tiling oligonucleotide array CGH.

Authors:  Rebecca R Selzer; Todd A Richmond; Nathan J Pofahl; Roland D Green; Peggy S Eis; Prakash Nair; Arthur R Brothman; Raymond L Stallings
Journal:  Genes Chromosomes Cancer       Date:  2005-11       Impact factor: 5.006

7.  Cytogenetics of Hispanic and White children with acute lymphoblastic leukemia in California.

Authors:  Melinda C Aldrich; Luoping Zhang; Joseph L Wiemels; Xiaomei Ma; Mignon L Loh; Catherine Metayer; Steve Selvin; James Feusner; Martyn T Smith; Patricia A Buffler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-03       Impact factor: 4.254

8.  Mutational and expression analysis of the chromosome 12p candidate tumor suppressor genes in pre-B acute lymphoblastic leukemia.

Authors:  A Montpetit; J Larose; G Boily; S Langlois; N Trudel; D Sinnett
Journal:  Leukemia       Date:  2004-09       Impact factor: 11.528

9.  Modeling first-hit functions of the t(12;21) TEL-AML1 translocation in mice.

Authors:  Shinobu Tsuzuki; Masao Seto; Mel Greaves; Tariq Enver
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-20       Impact factor: 11.205

10.  High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression.

Authors:  R P Kuiper; E F P M Schoenmakers; S V van Reijmersdal; J Y Hehir-Kwa; A Geurts van Kessel; F N van Leeuwen; P M Hoogerbrugge
Journal:  Leukemia       Date:  2007-04-19       Impact factor: 11.528

View more
  9 in total

1.  Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences.

Authors:  Leonora Balaj; Ryan Lessard; Lixin Dai; Yoon-Jae Cho; Scott L Pomeroy; Xandra O Breakefield; Johan Skog
Journal:  Nat Commun       Date:  2011-02-01       Impact factor: 14.919

2.  Roles of retrotransposons in benign and malignant hematologic disease.

Authors:  Anna M Schneider; Amy S Duffield; David E Symer; Kathleen H Burns
Journal:  Cellscience       Date:  2009-10-27

3.  Clone-specific secondary aberrations are not detected in neonatal blood spots of children with ETV6-RUNX1-positive leukemia.

Authors:  Maria Morak; Claus Meyer; Rolf Marschalek; Georg Mann; Oskar A Haas; Renate Panzer-Grümayer
Journal:  Haematologica       Date:  2013-09       Impact factor: 9.941

4.  DUSP16 is an epigenetically regulated determinant of JNK signalling in Burkitt's lymphoma.

Authors:  S Lee; N Syed; J Taylor; P Smith; B Griffin; M Baens; M Bai; K Bourantas; J Stebbing; K Naresh; M Nelson; M Tuthill; M Bower; E Hatzimichael; T Crook
Journal:  Br J Cancer       Date:  2010-06-15       Impact factor: 7.640

5.  Genomic inverse PCR for exploration of ligated breakpoints (GIPFEL), a new method to detect translocations in leukemia.

Authors:  Elisa Fueller; Daniel Schaefer; Ute Fischer; Pina F I Krell; Martin Stanulla; Arndt Borkhardt; Robert K Slany
Journal:  PLoS One       Date:  2014-08-19       Impact factor: 3.240

6.  12p deletion spectrum syndrome: a new case report reinforces the evidence regarding the potential relationship to autism spectrum disorder and related developmental impairments.

Authors:  Marcio Leyser; Bruno Leonardo Dias; Ana Luiza Coelho; Marcio Vasconcelos; Osvaldo J M Nascimento
Journal:  Mol Cytogenet       Date:  2016-10-04       Impact factor: 2.009

7.  Household exposure to paint and petroleum solvents, chromosomal translocations, and the risk of childhood leukemia.

Authors:  Ghislaine Scélo; Catherine Metayer; Luoping Zhang; Joseph L Wiemels; Melinda C Aldrich; Steve Selvin; Stacy Month; Martyn T Smith; Patricia A Buffler
Journal:  Environ Health Perspect       Date:  2008-10-10       Impact factor: 9.031

Review 8.  The role of extracellular vesicles in phenotypic cancer transformation.

Authors:  Eva Ogorevc; Veronika Kralj-Iglic; Peter Veranic
Journal:  Radiol Oncol       Date:  2013-07-30       Impact factor: 2.991

9.  Translocation junctions in TCF3-PBX1 acute lymphoblastic leukemia/lymphoma cluster near transposable elements.

Authors:  Nemanja Rodić; John G Zampella; Toby C Cornish; Sarah J Wheelan; Kathleen H Burns
Journal:  Mob DNA       Date:  2013-10-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.